The winner will depend on Phase 3 data, tolerability, approval timing, label breadth, payer access, and real-world persistence
Feb 27, 2026 The prevailing narrative around semaglutide and female sexuality goes something like this: lose weight, feel confident, watch your sex drive skyrocket
Following a February 2026 announcement by HHS Secretary RFK Jr., the FDA removed roughly 14 of those restricted peptides from Category 2 in April 2026
D, Medoro A, Siracusano M, Savino R, Saso L, Scapagnini G, Mazzone L (2025) Oxidative stress response and NRF2 signaling pathway in autism spectrum disorder
Regulations vary, so always check compliance
A randomised, double blind placebo controlled trial on 54 healthy adults assessed glutathione levels at one, three and six months